Teva Pharmaceutical Industries Limited Return on Equity

Teva Pharmaceutical Industries Limited (TEVJF) currently reports a ROE of 9.1%. That is below the Healthcare sector average of 11.15%. Use the charts on this page to explore Teva Pharmaceutical Industries Limited's ROE history and peer comparisons.

Teva Pharmaceutical Industries Limited's ROE of 9.1% is lower than the Healthcare sector average of 11.15%. That is roughly 18.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Teva Pharmaceutical Industries Limited's current 9.1% should be judged against Healthcare norms (sector average: 11.15%) and against TEVJF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 9.1%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for Teva Pharmaceutical Industries Limited, and consider following TEVJF for alerts when major investors trade the stock.

Teva Pharmaceutical Industries Limited is classified in the Healthcare sector. On ROE, it currently shows 9.1% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TEVJF with unrelated industries.